PMID- 3707656
OWN - NLM
STAT- MEDLINE
DCOM- 19860528
LR  - 20131121
IS  - 0004-4172 (Print)
IS  - 0004-4172 (Linking)
VI  - 36
IP  - 2A
DP  - 1986 Feb
TI  - Monitored long-term treatment with ibopamine in patients suffering from severe 
      congestive heart failure.
PG  - 394-7
AB  - 50 patients with congestive heart failure underwent monitored long-term treatment 
      aimed at evaluating the effect of ibopamine (SB-7505), the 3,4-diisobutyryl ester 
      of N-methyldopamine, on their condition. Ibopamine was administered alone or in 
      combination with traditional therapy mainly at a dose of 100 mg t.i.d. Clinical 
      scores and NYHA (New York Heart Association) functional classes improved. 
      Biochemical parameters showed no adverse modifications. Mild transient 
      side-effects probably related to ibopamine occurred in two patients.
FAU - Avanzini, Z
AU  - Avanzini Z
FAU - Bellogini, G C
AU  - Bellogini GC
FAU - Brusoni, B
AU  - Brusoni B
FAU - Ciampani, N
AU  - Ciampani N
FAU - Dei Cas, L
AU  - Dei Cas L
FAU - Gazzola, U
AU  - Gazzola U
FAU - Maggi, G C
AU  - Maggi GC
FAU - Mangiavacchi, M
AU  - Mangiavacchi M
FAU - Metra, M
AU  - Metra M
FAU - Pinca, L
AU  - Pinca L
AU  - et al.
LA  - eng
PT  - Journal Article
PL  - Germany
TA  - Arzneimittelforschung
JT  - Arzneimittel-Forschung
JID - 0372660
RN  - 0 (Cardiotonic Agents)
RN  - 8ZCA2I2L11 (ibopamine)
RN  - R7339QLN1C (Deoxyepinephrine)
RN  - VTD58H1Z2X (Dopamine)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Body Weight/drug effects
MH  - Cardiotonic Agents/adverse effects/*therapeutic use
MH  - Chronic Disease
MH  - Deoxyepinephrine/adverse effects/*analogs & derivatives/therapeutic use
MH  - Dopamine/*analogs & derivatives
MH  - Female
MH  - Heart Failure/*drug therapy/physiopathology
MH  - Heart Rate/drug effects
MH  - Hemodynamics/drug effects
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Monitoring, Physiologic
MH  - Time Factors
EDAT- 1986/02/01 00:00
MHDA- 1986/02/01 00:01
CRDT- 1986/02/01 00:00
PHST- 1986/02/01 00:00 [pubmed]
PHST- 1986/02/01 00:01 [medline]
PHST- 1986/02/01 00:00 [entrez]
PST - ppublish
SO  - Arzneimittelforschung. 1986 Feb;36(2A):394-7.